Connect with us
Despite the tragedy and turbulence of the Iran conflict, history offers a bracing truth: markets are ruthlessly efficient at discounting...
Greg Abel’s first annual meeting as Berkshire Hathaway CEO delivered a clear signal: patience and disciplined capital allocation will define the post-Buffett era. With a record...
Eight years after the largest European leveraged buyout of 2017, KKR is back at the table — this time on the sell side. The question is...
There is a moment in every structural transformation when the scaffolding of regulation quietly becomes architecture. Europe’s sustainable finance revolution crossed that threshold sometime between 2022...
The Onn 4K Streaming Stick doesn’t arrive with fanfare. It doesn’t need it. There were no press invites. No breathless product launches livestreamed to a million...
The Alabama startup boom is not an accident. It is not a fluke of geography, a windfall from a single anchor tenant, or the kind of...
Applications close May 27, 2026. TechCrunch Disrupt runs October 13–15 in San Francisco. The clock is already ticking — and the smartest founders I know aren’t...
How a board-game importer’s near-bankruptcy became the defining story of America’s small-business tariff refund battle — and what every importer needs to know right now. Jonathan...
“WHY are there so few exits in South-east Asia?” This is a fair and increasingly common question from limited partners in venture capital (VC). With disappointing...
Merck nears a $6bn all-cash acquisition of Terns Pharma and its CML drug TERN-701. Here’s the full strategic picture—what it means for patients, investors, and Big...